Glaukos will be the exclusive distributor of Santen’s MicroShunt in the United States, the companies announced.
The multi-year distribution agreement stipulates that Glaukos will be responsible for sales and distribution of the device, pending U.S. approval, while Santen continues to hold responsibility for manufacturing, quality and safety controls, regulatory activities and post-approval marketing requirements. according to a press release.
A minimally invasive ab externo surgical device, the MicroShunt is designed to treat primary open-angle glaucoma and is currently being studied in
Uncategorized